Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth

BMC Pediatrics

Ismael F Freitas Júnior²  Diego G Destro Christofaro²  Rômulo Araújo Fernandes²  Patrícia Monteiro Seraphim¹  Bárbara de Moura Mello Antunes³  Paula Alves Monteiro³  Loreana Sanches Silveira¹ 

[1] Department of Physiotherapy, UNESP, 421 Garcia Paes St. Jardim Paulista, 19023-060 Presidente Prudente, SP, Brazil;Department of Physical Education, UNESP, Presidente Prudente, SP, Brazil;Department of Physical Education, UNESP, Rio Claro, SP, Brazil

关键词: Trunk fat;    Non-alcoholic fatty liver disease;    Metabolic syndrome;    Adolescents;    Children;    Obesity;   

Others  :  1144674
DOI  :  10.1186/1471-2431-13-115

 received in 2013-01-17, accepted in 2013-08-02,  发布年份 2013

【 摘 要 】

Background

Previous studies have shown an association between adiposity, especially intra-abdominal adipose tissue, and hemodynamic/metabolic comorbidities in adults, however it is not clear in pediatric population. The aim of the study was to analyze the relationship between non-alcoholic fatty liver disease (NAFLD) and components of metabolic syndrome (MS) with values of intra-abdominal (IAAT) and subcutaneous (SCAT) adipose tissue in obese children and adolescents.

Methods

Cross-sectional study. Subjects: 182 obese sedentary children and adolescents (aged 6 to 16 y), identified by the body mass index (BMI). Measurements: Body composition and trunk fat by dual-energy X-ray absorptiometry- DXA; lipid profile, blood pressure and pubertal stage were also assessed. NAFLD was classified as absent (0), mild (1), moderate (2) and severe (3), and intra-abdominal and subcutaneous abdominal fat thickness were identified by ultrasound. The MS was identified according to the cut offs proposed by World Health Organization adapted for children and adolescents. The chi-square test was used to compare categorical variables, and the binary logistic regression indicated the magnitude of the associations adjusted by potential cofounders (sex, age, maturation, NAFLD and HOMA-IR).

Results

Higher quartile of SCAT was associated with elevated blood pressure (p = 0.015), but not associated with NAFLD (p = 0.665). Higher IAAT was positively associated with increased dyslipidemia (p = 0.001), MS (p = 0.013) and NAFLD (p = 0.005). Intermediate (p = 0.007) and highest (p = 0.001) quartile of IAAT were also associated with dyslipidemia, independently of age, sex, maturation, NAFLD and HOMA-IR (homeostatic model assessment-insulin resistance).

Conclusion

Obese children and adolescents, with higher IAAT are more prone to develop MS and NAFLD than those with higher values of SCAT, independent of possible confounding variables.

【 授权许可】

   
2013 Silveira et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Gupta N, Goel K, Shah P, Misra A: Childhood obesity in developing countries: epidemiology, determinants, and prevention. Endocr Rev 2012, 33(1):48-70.
• [2]Sundaram SS, Phil Z, Kristen N: The metabolic syndrome and non-alcoholic fatty liver disease in children. Curr Opin Pediatr 2009, 21(4):529-535.
• [3]Tominaga K, Fujimoto E, Suzuki K, Hayashi M, Ichikawa M, Inaba Y: Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. Environ Health Prev Med 2009, 14(2):142-149.
• [4]Després JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature 2006, 444(7121):881-887.
• [5]Huang PL: eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab 2009, 20(6):295-302.
• [6]Sinaiko A: Obesidade, resistência à insulina e síndrome metabólica. J Pediatr (Rio J) 2007, 83(1):3-5.
• [7]Fernandes RA, Zanesco A: Early physical activity promotes lower prevalence of chronic diseases in adulthood. Hypertens Res 2010, 33:926-931.
• [8]Fernandes RA, Christofaro DG, Casonatto J, Codogno JS, Rodrigues EQ, Cardoso ML, Kawaguti SS, Zanesco A: Prevalence of dyslipidemia in individuals physically active during childhood, adolescence and adult age. Arq Bras Cardiol 2011, 97(4):317-323.
• [9]Cole TJ, Bellizzi MC, Flegal KM, Dietz WH: Establishing a standard definition for child overweight and obesity worldwide: international survey. Bmj 2000, 320(7244):1240-1243.
• [10]Lohman T, Roche A, Martorell R: Anthropometric standardization reference manual. Champaign, Illinois. Human Kinetics 1988, 3-8.
• [11]Marshall WA, Tanner JM: Variations in pattern of pubertal changes in girls. Arch Dis Child 1969, 44(235):291-303.
• [12]Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970, 45(239):13-23.
• [13]Christofaro DG, Casonatto J, Polito MD, Cardoso JR, Fernandes R, Guariglia DA, Gerage AM, de Oliveira AR: Evaluation of the Omron MX3 Plus monitor for blood pressure measurement in adolescents. Eur J Pediatr 2009, 168(11):1349-1354.
• [14]National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114(2):555-576.
• [15]Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab Med 1998, 15:539-553.
• [16]Goran MI, Gower BA: Longitudinal study on pubertal insulin resistance. Diabetes 2001, 50(11):2444-2450.
• [17]Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
• [18]Moraes AC, Fulaz CS, Netto-Oliveira ER, Reichert FF: Prevalence of metabolic syndrome in adolescents: a systematic review. Cad Saude Publica 2009, 25(6):1195-1202.
• [19]Caranti DA, de Mello MT, Prado WL, Tock L, Siqueira KO, de Piano A, et al.: Short- and long-term beneficial effects of a multidisciplinary therapy for the control of metabolic syndrome in obese adolescents. Metabolism 2007, 56(9):1293-1300.
• [20]Lira Ana RF, Oliveira Fernanda LC, Escrivão Maria AMS, Colugnati Fernando AB, Taddei José AAC: Esteatose hepática em uma população escolar de adolescentes com sobrepeso e obesidade. J Pediatr (Rio J) 2010, 86(1):45-52.
• [21]Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Pennell CE, de Klerk N, Oddy WH, Shipman P, Adams LA: Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 2011, 53(3):800-809.
• [22]Barshop NJ, Francis CS, Schwimmer JB, Lavine JE: Nonalcoholic fatty liver disease as a comorbidity of childhood obesity. Ped Health 2009, 3(3):271-281.
• [23]Van Gaal LF, Mertens IL, De Block CE: Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444(7121):875-880.
• [24]Ronti T, Lupattelli G, Mannarino E: The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006, 64(4):355-365.
• [25]Lorenzo M, Fernandez-Veledo S, Vila-Bedmar R, Garcia-Guerra L, De Alvaro C, Nieto-Vazquez I: Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J Anim Sci 2008, 86(14 Suppl):E94-E104.
• [26]Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK: Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 2005, 54(10):2939-2945.
• [27]Wajchenberg BL: Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000, 21(6):697-738.
• [28]Matía MP, et al.: Nutrition and metabolic syndrome. Rev Esp Salud Publica 2007, 81(5):489-505.
• [29]Souza MSF, Leme RB, Franco RR: Síndrome metabólica em adolescentes com sobrepeso e obesidade. Rev paul pediatr [serial on the Internet] 2007, 25(3):214-220.
• [30]Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R, Feldstein AE, Nobili V: Ultrasonographic quantitative estimation of hepatic steatosis in children with Nafld.Jpgn. J Pediatr Gastroenterol Nutr 2011, 53:190-195.
• [31]Mazhar SM, Shiehmorteza M, Sirlin CB: Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 2009, 7:135-140.
• [32]Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ: Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 2009, 51:1061-1067.
• [33]Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH: Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatol 2004, 40:1387-1395.